Lymphedema Treatment Market Analysis, Trends, and Scope 2022 to 2028
Lymphedema Treatment Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 8.15 Billion |
| Market Size by 2028 | US$ 11.58 Billion |
| Global CAGR (2021 - 2028) | 5.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Condition Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
End-User - Based Insights
Based on end-user, the global lymphedema treatment market has been segmented into hospitals, clinics, clinical research organizations (CROs), and others (ambulatory care centers and primary care centers). The hospitals segment captured the largest market share in 2021. The clinics segment is expected to register the highest CAGR during the forecast period; the market growth of this segment can be ascribed to the fact that lymphedema treatments are mostly offered in specialized centers or units. Specialized surgical treatments such as liposuction and debulking procedures take place in specialty clinics that have a dedicated department for neurology, or more specifically, lymphedema treatment.
Product launches and approvals are commonly adopted strategies by companies in the lymphedema treatment market to expand their global footprints and product portfolios. Moreover, the market players focus on the partnership strategy to expand their clientele, which, in turn, allows them to maintain their brand name worldwide.
Company Profiles
- BIOCOMPRESSION SYSTEMS
- Tactile Medical
- Smith & Nephew
- BSN medical GmbH
- Lohmann & Rauscher GmbH & Co. KG
- SIGVARIS GROUP
- ThermoTek
- Huntleigh Healthcare Limited
- 3M
- Mego Afek ltd
Get Free Sample For